Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Váldodahkkit: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Oxford University Press
2018
|
Geahča maid
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Dahkki: Wattanakul, T, et al.
Almmustuhtton: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Dahkki: Thanaporn Wattanakul, et al.
Almmustuhtton: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
Dahkki: Chotsiri, P, et al.
Almmustuhtton: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
Dahkki: Pukrittayakamee, S, et al.
Almmustuhtton: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
Dahkki: Saito, M, et al.
Almmustuhtton: (2018)